Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma

Despite the rising incidence of human papillomavirus related (HPV+) oropharyngeal squamous cell carcinoma (OPSCC), treatment of metastatic disease remains palliative. Even with new treatments such as immunotherapy, response rates are low and can be delayed, while even mild tumor progression in the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Haring, Catherine T., Bhambhani, Chandan, Brummel, Collin, Jewell, Brittany, Bellile, Emily, Heft Neal, Molly E., Sandford, Erin, Spengler, Ryan M., Bhangale, Apurva, Spector, Matthew E., McHugh, Jonathan, Prince, Mark E., Mierzwa, Michelle, Worden, Francis P., Tewari, Muneesh, Swiecicki, Paul L., Brenner, J. Chad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238244/
https://www.ncbi.nlm.nih.gov/pubmed/34194620
http://dx.doi.org/10.18632/oncotarget.27992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238244/
https://www.ncbi.nlm.nih.gov/pubmed/34194620
http://dx.doi.org/10.18632/oncotarget.27992

Ejemplares similares